Occult chronic kidney disease among persons with hypertension in the United States: Data from the national health and nutrition surveys 1988-1994 and 1999-2002

Journal of Hypertension

Volumn 31, Issue 6, 2013, Pages 1196-1202

  Peralta, Carmen A ^a   Weekley, Cristin C ^a,b   Li, Yongmei ^b   Shlipak, Michael G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

albumin to creatinine ratio; chronic kidney disease; cystatin C; National Health and Nutrition Examination Survey

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HIGH RISK POPULATION; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NEGRO; NUTRITION; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE; UNITED STATES;

EID: 84877282414     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328360ae2d     Document Type: Article

References (23)

1. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001; 161:1207-1216.
2. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49(2 Suppl 2):S12-S154.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
4. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
5. British Hypertension Society: Hypertension Guidelines 2011. http://www.bhsoc.org/latest-guidelines/sub-page-11/. [Accessed 20 September 2012].
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL##Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
7. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-2483.
8. Agarwal R, Panesar A, Lewis RR. Dipstick proteinuria: can it guide hypertension management? Am J Kidney Dis 2002; 39:1190-1195.
9. Zeller A, Sigle JP, Battegay E, Martina B. Value of a standard urinary dipstick test for detecting microalbuminuria in patients with newly diagnosed hypertension. Swiss Med Wkly 2005; 135:57-61.
10. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073-2081.
11. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352:2049-2060.
12. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011; 305:1545-1552.
13. National Center for Health Statistics and Centers for Disease Control and Prevention: Analytic and reporting guidelines: The third National Health and Nutrition Examination Survey, NHANES III (1988-1994). http://www.cdc.gov/nchs/ nhanes/nh3rrm.htm#ag. Accessed September 20, 2012.
14. Foley RN, Wang C, Snyder JJ, Collins AJ. Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol 2009; 4:965-972.
15. HemmelgarnBR,Zhang J,Manns BJ, JamesMT,Quinn RR, Ravani P, et al. Nephrology visits and healthcare resource use before and after reporting estimated glomerular filtration rate. JAMA 2010; 303:1151-1158.
16. Selvin E, Manzi J, Stevens LA, van Lente F, Lacher DA, Levey AS, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 2007; 50:918-926.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
18. National Health and Nutrition Examination Survey (NHANES). Documentation, Codebook, and Frequencies: Surplus Specimen Laboratory Component: Cystatin C (Surplus Sera). 2007. http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/sscyst-b. pdf. Accessed September 20, 2012.
19. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51:395-406.
20. Peralta CA, Katz R, Sarnak MJ, Ix J, Fried IF, de Boer I, et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol 2011; 22:147-155.
21. Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens 2008; 17:266-270.
22. Marcantoni C, Ma LJ, Federspiel C, Fogo AB. Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int 2002; 62:172-180.
23. Bryson CL, Ross HJ, Boyko EJ, Young BA. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. Am J Kidney Dis 2006; 48:720-726.